z-logo
Premium
Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer
Author(s) -
Chu XiaoYuan,
Chen LongBang,
Wang JingHua,
Su QuanSheng,
Yang JiRong,
Lin Yong,
Xue LiJun,
Liu XiaoBei,
Mo XiaoBei
Publication year - 2011
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.22134
Subject(s) - survivin , colorectal cancer , cancer research , medicine , metastasis , gene knockdown , cancer , oncology , cell culture , biology , genetics
Abstract Background The aim of this study was to investigate the association of survivin expression with metastasis of colorectal cancer (CRC). Methods RT‐PCR and Western blot assays were performed to detect survivin expression in CRC cells and normal intestinal epithelial cell. The expression of survivin gene was also detected in 15 CRC tissues, surrounding and adjacent colon tissues. Moreover, survivin expression in 48 CRC tissues with or without lymph node metastasis was analyzed. Multivariate analysis for lymph node metastasis was performed using logistic regression model. RNA interference was used to inhibit survivin expression in CRC cells and analyze its effect on invasion and metastasis of CRC cells. Results The expression levels of survivin mRNA and protein were higher in CRC cells than in normal intestinal epithelial cell line. The average levels of survivin mRNA and protein were higher in CRC tissues than surrounding or adjacent colon tissues ( P  < 0.05). High survivin expression was an independent factor for predicting lymph node metastasis of CRC ( P  = 0.043). RNAi‐mediated survivin knockdown could significantly inhibit in vitro invasion and in vivo metastasis of CRC cells, which might be inactivation of matrix metalloproteinases. Conclusion Targeting survivin will be a potential strategy to suppress metastasis of CRC. J. Surg. Oncol. 2012; 105:520–528. © 2011 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here